July/August 2010, Vol 3, No 4

Regulatory

Accountable Care Organizations in the Era of Healthcare Reform
Interview with Mark B. McClellan, MD, PhD

Business

Expect the Unexpected: A Role for Behavioral Economics in Understanding the Impact of Cost- Sharing on Emergency Department Utilization
Albert Tzeel, MD, MHSA
; Jack Brown, BA
Stakeholder Perspective by Alberto M. Colombi, MD, MPH
Comparing Medical Cost of Care for Patients with Metastatic Breast Cancer Receiving Taxane Therapy: Claims Analysis
Rex W. Force, PharmD
; Brooke A. Pugmire, PharmD
; Vaughn L. Culbertson, PharmD
Stakeholder Perspective by Atheer A. Kaddis, PharmD

Clinical

Effectiveness of Anti-Tumor Necrosis Factor Agents in the Treatment of Rheumatoid Arthritis: Observational Study
Anna D’Souza, PhD
; Brian L. Meissner, PharmD, PhD
; Boxiong Tang, MD, PhD
; R. Scott McKenzie, MD
; Catherine T. Piech, MBA
Stakeholder Perspective by Matthew Mitchell, PharmD, MBA

Healthcare Reform

The New Accountable Care Organizations and Medicare Gain-Sharing Program
Kip Piper, MA, FACHE
The Impact of Healthcare Reform on Payers’ Products, Provider Reimbursement, and Member Engagement
Sam Muppalla
; Robert Capobianco

Generic Drug Trends

Enhanced Generic Utilization Saved US Healthcare $139.6 Billion in 2009
Dalia Buffery, MA, ABD

Industry Trends

The Current State of Bundled Payments
Jim Evans